Suman Kumar Samanta

Statistics

Publications

Citations

795

H-Index

Active since

2009

Affiliations

Institute of Advanced Study in Science and Technology(Current)

Indian Institute of Chemical Biology

Council of Scientific and Industrial Research

National Institute of Pharmaceutical Education and Research

UPMC Hillman Cancer Center

Suman Kumar Samanta is an author at Institute of Advanced Study in Science and Technology specializing in oncology, pharmacology, and molecular oncology.

ORCID

Publications per year

2009–2022

Publications

Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways

Suman Kumar Samanta, R. P. Tripathi, Asish Mallick et al. · Biochemical Pharmacology · 2009 · 87 citations

Life Sciences, Cell Biology, Oncology +17

Ricinus communis L. fruit extract inhibits migration/invasion, induces apoptosis in breast cancer cells and arrests tumor progression in vivo

Munmi Majumder, Shibjyoti Debnath, Rahul L. Gajbhiye et al. · Scientific Reports · 2019 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Oxidative inhibition of Hsp90 disrupts the super‐chaperone complex and attenuates pancreatic adenocarcinoma <i>in vitro</i> and <i>in vivo</i>

Sayantani Sarkar, Devawati Dutta, Suman Kumar Samanta et al. · International Journal of Cancer · 2012 · 65 citations

Medicine, Oncology, Pharmacology +16

Mahanine, a novel mitochondrial complex-III inhibitor induces G0/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme.

Kaushik Bhattacharya, Arup K. Bag, R. P. Tripathi et al. · PubMed · 2014 · 60 citations

Medicine, Cancer Biology, Pharmacology +17

Improved chemosensitivity in cervical cancer to cisplatin: Synergistic activity of mahanine through STAT3 inhibition

Ranjita Das, Suman Kumar Samanta, Bikas C. Pal et al. · Cancer Letters · 2014 · 59 citations

Medicine, Oncology, Pharmacology +16

1–5 of 21